Emerging at the UK, retatrutide, a new molecule, is sparking considerable interest within the scientific community regarding its potential for weight management . This dual GIP and GLP-1 target agonist appears to provide a significant advantage over current therapies, showing encouraging results in early clinical studies . Researchers believe it… Read More